The Hyderabad-based Shantha Biotechnics, recently acquired by the Sanofi-Pasteur - the vaccines division of sanofi-aventis Group, has bagged US$ 340 million worth contract from the United Nations Agency to supply its pentavalent vaccine Shan5 for the period 2010-2012.
The details can be read here.
No comments:
Post a Comment